Stockreport

Cytori Reports Summary of FDA Feedback Regarding its ATI-1123 Product

CYTORI THERAPEUTICS  (CYTX) 
Last cytori therapeutics earnings: 11/14 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytori.com/investor-relations/default.aspx
PDF AUSTIN, Texas, July 01, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) today provided an update on the development of its proprietary drug, ATI-1123 [Read more]